Literature DB >> 14263635

REFRACTORY ANEMIA WITH ABNORMAL IRON METABOLISM: ITS REMISSION AFTER RESECTION OF HYPERPLASTIC MEDIASTINAL LYMPH NODES.

S L LEE, F ROSNER, I RIVERO, F FELDMAN, A HURWITZ.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPOCHROMIC; BLOOD PROTEIN DISORDERS; BONE MARROW EXAMINATION; CHILD; DIAGNOSIS, DIFFERENTIAL; FEVER; GAMMA GLOBULIN; HYPERPLASIA; IRON METABOLISM; LYMPH NODE EXCISION; LYMPH NODES; MEDIASTINAL NEOPLASMS; MEDIASTINUM; PATHOLOGY; PLASMA CELLS; SPLENOMEGALY

Mesh：

Substances：

Year:  1965        PMID： 14263635     DOI： 10.1056/NEJM196504152721502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients.

Authors:  Y Baruch; Y Ben-Arie; H Kerner; M Lorber; L A Best; R Gershoni-Baruch
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

2.  Angiofollicular lymph node hyperplasia (Castleman).

Authors:  D Anagnostou; C V Harrison
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

3.  Unusual mediastinal tumour.

Authors: 
Journal:  Br Med J       Date:  1965-11-20

4.  Castleman's disease in identical twins.

Authors:  C Martin; M L Peña; F Angulo; F García; D Vaca; R Serrano
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

5.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Authors:  S J Brandt; D M Bodine; C E Dunbar; A W Nienhuis
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Iron therapy resistant microcytic anaemia in a 13-year-old girl with Castleman disease.

Authors:  T A De Heer-Groen; A B Prakken; N M Bax; P J van Dijken
Journal:  Eur J Pediatr       Date:  1996-12       Impact factor: 3.183

7.  Giant lymph node hyperplasia of the mediastinum and refractory anaemia.

Authors:  C G Geary; H Fox
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

8.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

9.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

10.  Intra-abdominal localized hyaline-vascular Castleman disease: imaging characteristics and management of a rare condition.

Authors:  Nikolaos Vassos; Dimitrios Raptis; Michael Lell; Peter Klein; Aristotelis Perrakis; Jens Köhler; Roland S Croner; Werner Hohenberger; Abbas Agaimy
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.